Full Text Available

Note: Clicking the button above will open the full text document at the original institutional repository in a new window.

Carcinoembryonic Antigen Flare Under Oxaliplatin-Based Chemotherapy Predicts Benefit from Nivolumab in Metastatic Microsatellite-Stable Colorectal Cancer – A Post Hoc Analysis of METIMMOX Trial Data

Saved in:
Bibliographic Details
Published in:ImmunoTargets and Therapy
Format: Online Article RSS Article
Published: 2026
Subjects:
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1868553704651620353
collection WordPress RSS
FRELIP Feed Integration
container_title ImmunoTargets and Therapy
description
discipline_display Allergology and Immunology
discipline_facet Allergology and Immunology
format Online Article
RSS Article
genre Journal Article
id rss_article:84496
institution FRELIP
journal_source_facet ImmunoTargets and Therapy
last_indexed 2026-06-20T21:41:14.952Z
publishDate 2026
publishDateSort 2026
record_format rss_article
spellingShingle Carcinoembryonic Antigen Flare Under Oxaliplatin-Based Chemotherapy Predicts Benefit from Nivolumab in Metastatic Microsatellite-Stable Colorectal Cancer – A Post Hoc Analysis of METIMMOX Trial Data
Allergology and Immunology
General
Allergology and Immunology
sub_discipline_display General
sub_discipline_facet General
subject_display Allergology and Immunology
General
Allergology and Immunology
subject_facet Allergology and Immunology
General
Allergology and Immunology
title Carcinoembryonic Antigen Flare Under Oxaliplatin-Based Chemotherapy Predicts Benefit from Nivolumab in Metastatic Microsatellite-Stable Colorectal Cancer – A Post Hoc Analysis of METIMMOX Trial Data
title_alt El aumento del antígeno carcinoembrionario bajo quimioterapia basada en oxaliplatino predice el beneficio de nivolumab en cáncer colorrectal metastásico microsatélite estable: un análisis post hoc de los datos del ensayo METIMMOX
Flare de l'antigène carcinoembryonnaire sous chimiothérapie à base d'oxaliplatine prédit le bénéfice du nivolumab dans le cancer colorectal métastatique microsatellite stable — analyse post-hoc des données de l'essai METIMMOX
Flare do Antígeno Carcinoembrionário sob Quimioterapia à Base de Oxaliplatina Prediz Benefício do Nivolumabe no Câncer Colorretal Metastático Microssatélite Estável – Uma Análise Post Hoc dos Dados do Ensaio METIMMOX
title_auth Carcinoembryonic Antigen Flare Under Oxaliplatin-Based Chemotherapy Predicts Benefit from Nivolumab in Metastatic Microsatellite-Stable Colorectal Cancer – A Post Hoc Analysis of METIMMOX Trial Data
title_es_txt El aumento del antígeno carcinoembrionario bajo quimioterapia basada en oxaliplatino predice el beneficio de nivolumab en cáncer colorrectal metastásico microsatélite estable: un análisis post hoc de los datos del ensayo METIMMOX
title_fr_txt Flare de l'antigène carcinoembryonnaire sous chimiothérapie à base d'oxaliplatine prédit le bénéfice du nivolumab dans le cancer colorectal métastatique microsatellite stable — analyse post-hoc des données de l'essai METIMMOX
title_full Carcinoembryonic Antigen Flare Under Oxaliplatin-Based Chemotherapy Predicts Benefit from Nivolumab in Metastatic Microsatellite-Stable Colorectal Cancer – A Post Hoc Analysis of METIMMOX Trial Data
title_fullStr Carcinoembryonic Antigen Flare Under Oxaliplatin-Based Chemotherapy Predicts Benefit from Nivolumab in Metastatic Microsatellite-Stable Colorectal Cancer – A Post Hoc Analysis of METIMMOX Trial Data
title_full_unstemmed Carcinoembryonic Antigen Flare Under Oxaliplatin-Based Chemotherapy Predicts Benefit from Nivolumab in Metastatic Microsatellite-Stable Colorectal Cancer – A Post Hoc Analysis of METIMMOX Trial Data
title_pt_txt Flare do Antígeno Carcinoembrionário sob Quimioterapia à Base de Oxaliplatina Prediz Benefício do Nivolumabe no Câncer Colorretal Metastático Microssatélite Estável – Uma Análise Post Hoc dos Dados do Ensaio METIMMOX
title_short Carcinoembryonic Antigen Flare Under Oxaliplatin-Based Chemotherapy Predicts Benefit from Nivolumab in Metastatic Microsatellite-Stable Colorectal Cancer – A Post Hoc Analysis of METIMMOX Trial Data
title_sort carcinoembryonic antigen flare under oxaliplatin-based chemotherapy predicts benefit from nivolumab in metastatic microsatellite-stable colorectal cancer – a post hoc analysis of metimmox trial data
topic Allergology and Immunology
General
Allergology and Immunology
url https://www.dovepress.com/carcinoembryonic-antigen-flare-under-oxaliplatin-based-chemotherapy-pr-peer-reviewed-fulltext-article-ITT